Capecitabine for ER-positive versus ER-negative breast cancer
Publication Details
White, A. M.,
Lau, P. K.,
Redfern, A. D.,
&
Bulsara, M. K.
(2014).
Capecitabine for ER-positive versus ER-negative breast cancer.
The Cochrane Library,.
https://doi.org/10.1002/14651858.CD011220
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.
Keywords
breast cancer, capecitabine, review protocol
